FDA Moves To Pull Breast Cancer Approval For Avastin
The U.S. Food and Drug Administration has begun the process of pulling its approval of Genentech Inc.'s blockbuster cancer drug Avastin for use in breast cancer patients, announcing Thursday that the...To view the full article, register now.
Already a subscriber? Click here to view full article